CDC to lay off hundreds in restructuring

Metabolic syndrome (MetS) is associated with an increased risk for Parkinson's disease (PD), according to a study published online Aug. 20 in Neurology.

The U.S. Food and Drug Administration has approved Papzimeos (zopapogene imadenovec-drba) for the treatment of adults with recurrent respiratory papillomatosis (RRP).

Health experts across the country are issuing warnings about a surge in infections from a "flesh-eating" bacterium known as Vibrio vulnificus.

Women with cirrhosis and ascites experience worse health-related quality of life (HRQoL) than men, although no difference is seen in daily function, according to a study published in the August issue of the American Journal of Gastroenterology.

A preclinical evaluation of a new "dual-mode" tracer agent shows promise in not only helping surgeons image and plan prostate cancer procedures, but also provide them with much more consistent and targeted guidance during surgery.

Researchers at the Leibniz Institute for Plasma Science and Technology (INP) have collaborated with partners at Greifswald University Hospital and University Medical Center Rostock to demonstrate that cold plasma can effectively combat tumor cells even in deeper tissue layers.

In adults with autoimmune pulmonary alveolar proteinosis (aPAP), once-daily inhaled molgramostim, a recombinant human granulocyte-macrophage colony-stimulating factor, leads to a greater increase in pulmonary gas transfer than placebo, according to a study published in the Aug. 21/28 issue of the New England Journal of Medicine.

A new study finds a dramatic increase in safe drinking water when a machine learning-enabled tool created by York University researchers is used to optimize chlorination levels in refugee camp water supplies. Lead author Syed Imran Ali says that the new study shows that the Safe Water Optimization Tool (SWOT) vastly outperforms status-quo guidelines for safe water supply in humanitarian response.

A resident of South Lake Tahoe, California, has been diagnosed with the plague, the state's first human plague infection since 2020.

A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy everolimus to standard carboplatin chemotherapy extends the time before disease progression in patients with advanced triple-negative breast cancer (TNBC), one of the most aggressive and hard-to-treat forms of breast cancer.

From virtual counselors that can hear depression creeping into a person's voice to smart watches that can detect stress, artificial intelligence is poised to revolutionize mental health care for patients with breast cancer.

Could blowing a conch shell help treat sleep apnea? As a doctor working in sleep medicine, this unexpected news story certainly grabbed my attention. My first reaction was skepticism—sleep specialists don't typically prescribe natural objects found on beaches as medical therapy. But perhaps I was too hasty to dismiss the idea.

In 2024, Hurricane Helene triggered a nationwide shortage of the country's intravenous (IV) fluids after damaging a facility in North Carolina. A similar IV fluid shortage was caused when Hurricane Maria hit Puerto Rico in 2017.

A handheld sensor and innovative technique developed by Texas A&M AgriLife Research scientists could one day offer a noninvasive alternative to food diaries and blood tests when monitoring diet and health.

A team of researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai has successfully treated a rare and aggressive T-cell lymphoma that developed after CAR T-cell therapy for multiple myeloma, marking a first in the field of hematologic cancer research. The findings were published in the New England Journal of Medicine.

Researchers from Kumamoto University have identified a distinctive CT imaging pattern that can predict which women experiencing severe postpartum hemorrhage (PPH) are most likely to need life-saving interventions.

Whether it's a glass of red wine with dinner or a celebratory cocktail on the weekend, drinking in moderation has long been considered not only socially acceptable but also perhaps even healthy.

Researchers from the Roger Williams Institute of Liver Studies at King's College London developed two 3D models from human tissue to understand the effects that a drug—a cyclophilin inhibitor—has on liver tissue damaged by alcohol. They found that the drug stops the build-up of proteins responsible for making the tissue stiff—a characteristic of liver disease—allowing the liver to remodel itself back to a healthier state.